The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines

by Barda, N., Dagan, N.
Published 2022

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting

by Balicer, R., Barda, N., Dagan, N., Leader, A., Magen, O., Mittelman, M., Oster, H.S
Published 2022

Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel

by Balicer, R.D, Barda, N., Dagan, N., Makov-Assif, M., Netzer, D., Reis, B.Y, Waxman, J.G
Published 2022

Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)

by Akriv, A., Amichay, D., Avni, Y.S, Balicer, R.D, Barda, N., Berdinstein, R., Chayat, C.B, Chazan, B., Chowers, M., Dagan, N., Dor, A.B, Greenberg, D., Harlev, E.B, Hirsch, A., Katz, M.A, Kepten, E., Levy, J., Mandelboim, M., Peretz, A., Rainy, N., Rashid, G., Reznik, D., Sagas, D., Taraday, E.K, Tshori, S., Weinberger, R., Yacobi, M., Zuckerman, N., Zvi, H.B
Published 2022